New YorkRelates to the availability of opioid reversal agents
What it does
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jan 12REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERSLatest
- Vote recorded Assembly Vote - Vote 2. Result: pass.Lower
- Jan 12DELIVERED TO SENATE
- Jan 12PASSED ASSEMBLYPassed 2nd Chamber
- Jan 7ORDERED TO THIRD READING CAL.9
- Jan 7RETURNED TO ASSEMBLY
- Jan 7DIED IN SENATE
- Jan 12REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERSLatest
- 2025
- Jun 13DELIVERED TO SENATE
- Vote recorded Assembly Vote. Result: pass.Lower
- Jun 13PASSED ASSEMBLYPassed 1st Chamber
- Jun 13ORDERED TO THIRD READING RULES CAL.705
- Jun 13RULES REPORT CAL.705
- Jun 13REPORTED
- Jun 13REPORTED REFERRED TO RULESMinor
- Feb 11REPORTED REFERRED TO WAYS AND MEANSMinor
- Jan 10PRINT NUMBER 265AMajor
- Jan 10AMEND AND RECOMMIT TO ALCOHOLISM AND DRUG ABUSEMajor
- Jan 8REFERRED TO ALCOHOLISM AND DRUG ABUSEIntroduced
- Jun 13DELIVERED TO SENATE